The Centers for Medicare & Medicaid Services yesterday proposed repealing a final rule codifying how it defines “reasonable and necessary” coverage for items and services furnished under Medicare Parts A and B, which is scheduled to take effect Dec. 15. The final rule also establishes a Medicare coverage pathway for innovative medical devices designated as breakthrough by the Food and Drug Administration. Beginning tomorrow, CMS will accept comments for 30 days on the proposed repeal and the agency’s intent to conduct future rulemaking to explore the definition of “reasonable and necessary” coverage and an expedited coverage pathway for innovative beneficial technologies. 

In comments submitted last November, AHA warned against an earlier proposal that national and local Medicare coverage determinations consider the extent to which certain items or services are covered by a majority of commercial insurers, noting that such an approach could reduce coverage in the Medicare program and transparency in coverage determinations.
 

Headline
The Centers for Medicare & Medicaid Services July 27 released its Contract Year 2025 Part C and Part D Program Audit and Enforcement Report, outlining key…
Headline
The Centers for Medicare & Medicaid Services has released an updated FAQ on Protecting Access to Medicare Act private payer data reporting. The deadline is…
Headline
The Centers for Medicare & Medicaid Services July 16 released draft guidance for the 2028 cycle of negotiations under the Medicare Drug Price Negotiation…
Headline
The Centers for Medicare & Medicaid Services July 1 launched the Medicare GLP-1 Bridge, a short-term demonstration program designed to provide eligible…
Headline
A blog by Noah Isserman, AHA director of health insurance and coverage policy, explains why a recent analysis by the Medicare Payment Advisory Commission…
Blog
Public
Medicare Advantage now covers more than half of eligible Medicare beneficiaries, making its impact on hospitals, health systems and patients impossible to…